Nektar Therapeutics
NKTR
#4257
Rank
C$3.77 B
Marketcap
C$127.33
Share price
-5.06%
Change (1 day)
873.04%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): C-$5.94

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$5.78. In 2024 the company made an earnings per share (EPS) of C-$4.78 an increase over its 2023 EPS that were of C-$29.92.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.9424.31%
2024C-$4.78-84.02%
2023C-$29.92-25.89%
2022C-$40.37-31.12%
2021C-$58.6214.86%
2020C-$51.03-1.19%
2019C-$51.65-163.96%
2018C$80.75-725.4%
2017C-$12.91-42.73%
2016C-$22.5483.33%
2015C-$12.3039.53%
2014C-$8.81-69.29%
2013C-$28.69-6.67%
2012C-$30.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.22-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.86-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.58-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.53-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.99-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$8.10-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
C$0.09564-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C$2.83-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland